Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$989K Buy
+106,427
New +$1.05M ﹤0.01% 787
2025
Q4
Sell
-584,794
Closed -$3.34M 1138
2025
Q3
$3.34M Buy
+584,794
New +$3.12M 0.01% 587
2025
Q1
Sell
-23,371
Closed -$284K 755
2024
Q4
$284K Sell
23,371
-10,153
-30% -$142K ﹤0.01% 635
2024
Q3
$564K Sell
33,524
-4,759
-12% -$78.3K ﹤0.01% 676
2024
Q2
$598K Sell
38,283
-4,833
-11% -$67.2K ﹤0.01% 731
2024
Q1
$680K Sell
43,116
-6,710
-13% -$112K ﹤0.01% 599
2023
Q4
$1M Sell
49,826
-1,986
-4% -$33.6K 0.01% 634
2023
Q3
$961K Sell
51,812
-172,555
-77% -$3.76M 0.01% 613
2023
Q2
$4.88M Sell
224,367
-8,908
-4% -$161K 0.03% 314
2023
Q1
$4.32M Sell
233,275
-1,345
-0.6% -$25.3K 0.03% 334
2022
Q4
$3.57M Sell
234,620
-75,079
-24% -$1.07M 0.02% 426
2022
Q3
$4.33M Buy
309,699
+137,713
+80% +$2.77M 0.02% 415
2022
Q2
$4.14M Buy
171,986
+15,893
+10% +$426K 0.02% 531
2022
Q1
$4.81M Buy
156,093
+37,044
+31% +$1.33M 0.02% 482
2021
Q4
$5.41M Buy
119,049
+19,806
+20% +$847K 0.03% 279
2021
Q3
$4.31M Sell
99,243
-7,727
-7% -$336K 0.02% 310
2021
Q2
$4.92M Buy
+106,970
New +$4.94M 0.03% 332

Other funds holding NEOG

Ray Dalio's NEOG Position: Q1 2026 in Review

Ray Dalio opened a new position in Neogen (NEOG) in Q1 2026: 106,427 shares worth $989K. The stake represents ﹤0.01% of the portfolio and ranks #787 among its holdings. This is a return to the name: Ray Dalio previously reported a position in NEOG as recently as Q3 2025.

Ray Dalio first reported a position in NEOG in Q2 2021 and has held it in 17 quarters since. The position peaked at $5.41M in Q4 2021. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • Ray Dalio held 106,427 shares of Neogen worth $989K as of Q1 2026.
  • Neogen was a new Ray Dalio position in Q1 2026.
  • Neogen made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #787 holding.
  • Ray Dalio first reported a position in Neogen in Q2 2021 and has held it in 17 quarters since.
  • Ray Dalio's Neogen position peaked at $5.41M in Q4 2021.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.